This is to announce that due to the delisting of Ayrton Drug Manufacturing Limited (AYRTN) and Starwin Products Limited (SPL) and subsequent listing of Dannex Ayrton Starwin Plc (DASPHARMA) as a result of the merger of the three companies. Trading in the shares of AYRTN and SPL will be suspended from Thursday January 9, 2020 until they are delisted on Wednesday January 15,
2020.
Please find attached the press release announcing the merger as well as the timetable of events leading to the delisting of AYRTN and SPL and listing of DASPHARMA.
Issued in Accra, this 8 th day of January, 2020